Insulin
-
Bloomberg Law: Minnesota Sued Over New Law Providing Free Insulin to the Poor
Tags: Insulin
Read more: Bloomberg Law: Minnesota Sued Over New Law Providing Free Insulin to the PoorHCCI’s research on insulin prices was featured in a Bloomberg Law article. From the article: “The inventor who discovered insulin in the 1920s famously sold the patent to the University of Toronto for $1 in the hope that anyone who needed it could afford it.In the years since, the four most common types of insulin have…
-
Boston Globe: Senate leaders to offer antidote for high drug costs
Read more: Boston Globe: Senate leaders to offer antidote for high drug costsHCCI’s work on insulin pricing was cited in a Boston Globe article. From the article: “Following similar efforts in Colorado and Minnesota, the Senate bill also targets the costs of insulin, a commonly used drug that has become increasingly unaffordable for many patients. On average, the price of all types of insulin roughly doubled between…
-
Insulin Use Explains Variation in Level, but not Growth, of Out-of-Pocket Spending on Insulin Products
Read more: Insulin Use Explains Variation in Level, but not Growth, of Out-of-Pocket Spending on Insulin ProductsWe previously published two blogs discussing trends in out-of-pocket spending on insulin products. First, we presented data illustrating how average monthly out-of-pocket spending in 2017 varied considerably by month, particularly for individuals enrolled in consumer-directed health plans (CDHPs) that carry higher deductibles. Second, we examined the relationship between increasing point-of-sale prices between 2012 and 2017…
-
Rising Point-of-Sale Prices for Insulin Correspond with Higher Out-of-Pocket Spending on Insulin in January
Read more: Rising Point-of-Sale Prices for Insulin Correspond with Higher Out-of-Pocket Spending on Insulin in JanuaryEarlier this week we presented data on out-of-pocket spending on insulin during each month in 2017. In that blog, we showed that enrollees in employer-sponsored health insurance paid more out-of-pocket for insulin products at the beginning of the calendar year. We examined the relationship between increasing point-of-sale prices for insulin and higher out-of-pocket spending in…
-
Out-of-Pocket Spending on Insulin is Highest at the Beginning of the Year
Tags: Commercially Insured, Consumer-Directed Health Plans, Diabetes, Drug Spending, Geographic Variation, Insulin
Read more: Out-of-Pocket Spending on Insulin is Highest at the Beginning of the YearPeople who get health insurance through their jobs pay more than twice as much for insulin at the beginning of the year than they do at the end of the year, on average. New analysis of HCCI data shows that, nationally, in January 2017, average out-of-pocket spending on insulin was $105. This spending declined every…
-
CNBC: Eli Lilly Confirms Probe by New York’s Attorney General over Insulin Prices
Read more: CNBC: Eli Lilly Confirms Probe by New York’s Attorney General over Insulin PricesHCCI’s research on insulin prices was mentioned in a CNBC report. From the article: “The Centers for Disease Control and Prevention estimates more than 30 million Americans have diabetes. The annual cost of insulin for people with Type 1 diabetes in the U.S. nearly doubled from 2012 to 2016 to $5,700 from $2,900, according to an analysis…
-
HCCI will be presenting at AcademyHealth’s 2019 Annual Research Meeting
Read more: HCCI will be presenting at AcademyHealth’s 2019 Annual Research MeetingThe Health Care Cost Institute (HCCI) is proud to present five posters at the AcademyHealth 2019 Annual Research Meeting in Washington, D.C. These posters, which cover HCCI research on a wide variety of topics, focus on health care spending and utilization trends among the commercially insured population. If you are attending the conference, please check…
-
The New York Times: Express Scripts Offers Diabetes Patients a $25 Cap for Monthly Insulin
Read more: The New York Times: Express Scripts Offers Diabetes Patients a $25 Cap for Monthly InsulinHCCI’s research on rising insulin list prices was recently cited by The New York Times in its reporting on Express Scripts’ new plan to offer a $25 cap for month insulin. From the article: “Consumers whose drug benefits are managed by Express Scripts could see their out-of-pocket costs for insulin limited to $25 a month…
-
HCCI Research Used in Support of Congressional Inquiries
Read more: HCCI Research Used in Support of Congressional InquiriesHCCI’s recent report on rising insulin prices was cited in support of congressional inquiries into drug pricing. This included a letter from U.S. Senator Tim Kaine (D-VA) to executives at Eli Lilly, Novo Nordisk, and Sanofi requesting information on insulin pricing. Additionally, HCCI’s research on emergency care was cited in a letter from U.S. Senators Bill Cassidy…
-
HCCI Insulin Report Receives Extensive Media Coverage
Tags: CBS, Chronic Conditions, CNN, Diabetes, Drug Spending, HCCI News, Insulin, NBC, Prices, The New York TimesRead more: HCCI Insulin Report Receives Extensive Media CoverageHCCI’s recent report on trends in rising insulin prices received additional media coverage in the last week in outlets including NBC, CBS, CNN, The New York Times, The Hill, U.S. News & World Report, and USA Today. From CNN: “Congress and the Trump administration continue to push for a drug pricing plan and were given more…